1. Home
  2. CLOV
  3. Earnings

AI Earnings Predictions for Clover Health Investments Corp. (CLOV)

Machine learning predictions based on historical earnings data and price patterns

Latest Prediction

SELL

1-Day Prediction

-7.38%

$3.97

0% positive prob.

5-Day Prediction

-11.97%

$3.78

0% positive prob.

20-Day Prediction

-10.39%

$3.84

0% positive prob.

Price at prediction: $4.29 Confidence: 100.0% Model AUC: 1.0000 Quarter: Q3 2026

Historical Earnings Predictions

Quarter Signal 1D Return 5D Return 20D Return Confidence Actual 5D
Q3 2026 SELL -7.38% -11.97% -10.39% 100.0% Pending
Q2 2026 BUY +0.25% +13.75% +11.24% 100.0% Pending
Q1 2026 BUY -0.75% +10.01% +3.71% 100.0% +32.46%
Q4 2025 SELL -7.52% -12.39% -8.98% 90.3% -4.60%

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q3

Q3 2026 Earnings

8-K SELL

Nov 4, 2026 · 100% conf.

AI Prediction SELL

1D

-7.38%

$3.97

Act: -4.07%

5D

-11.97%

$3.78

20D

-10.39%

$3.84

Price: $4.29 Prob +5D: 0% AUC: 1.000
0001801170-26-000291

EX-99.1

2 a3q26exx991xearningsrelease.htm

EX-99.1

Document

Exhibit 99.1

Clover Health Reports Third Quarter 2026 Results

Business Highlights:

•Strong third quarter performance brings year-to-date GAAP Net Income to $62 million alongside 49% year-over-year Medicare Advantage membership growth

•Improved Full Year 2026 guidance across all metrics

•2027 AEP tracking well, with significant growth due to strong product positioning in core markets

•Clover’s flagship PPO, representing ~98% of current membership, received a 5 Star rating for Payment Year 2028

Financial Results:

•Third quarter 2026 GAAP Net Income of $6 million, an improvement of $31 million year-over-year

•Third quarter 2026 Medicare Advantage membership of 158,907, up 45% year-over-year, and Total revenues of $759 million, up 53% year-over-year

•Third quarter 2026 Consolidated Gross Profit of $130 million, up 77% year-over-year, and Adjusted EBITDA of $16 million, up $14 million year-over-year

Improved Full Year 2026 Guidance:

•Average Medicare Advantage membership of 157,000 - 158,000, representing 47% growth year-over-year at the midpoint

•Total revenues between $2.97 billion and $3.00 billion, representing 55% growth year-over-year at the midpoint

•GAAP Net Income between $25 million and $35 million

•Consolidated Gross Profit between $540 million and $555 million, representing 54% growth year-over-year at the midpoint

•Adjusted EBITDA profitability between $75 million and $85 million

WILMINGTON, Del. – November 4, 2026 – Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the third quarter 2026. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights.

“Our results further demonstrate our technology-powered differentiation, and how earlier and better care management, market-leading growth, and increasing profitability can reinforce one another under the right model,” said Clover Health CEO Andrew Toy. "Through Clover Assistant, we are committed to delivering better clinical quality and lower total cost of care. We are pleased that this continues to show up in our results, with ~98% of our members enrolled in our 5 Star rated PPO for Payment Year 2028, alongside our third consecutive year of nation-leading HEDIS performance.”

"In 2026, Clover is on track to have grown significantly and expects to deliver its first full year of GAAP Net Income profitability,” said Clover Health CFO Clay Thornton. “With our largest member cohorts maturing, continued operating leverage, and strong Star ratings performance, we believe we are well positioned for meaningful earnings expansion in 2027.”

1

Key Company highlights are as follows:

Three Months Ended September 30,Nine Months Ended September 30,

Dollars in Millions20262025Change (%)20262025Change (%)

Consolidated:

Total revenues$759.3 $496.7 52.9 %$2,251.7 $1,436.6 56.7 %

Consolidated Gross profit(1) $129.8 $73.2 77.3 %$442.4 $281.7 57.0 %

Salaries and benefits plus General and administrative expenses ("SG&A")$122.8 $97.1 26.5 %$378.9 $316.6 19.7 %

Adjusted Salaries and benefits plus General and administrative expenses ("Adjusted SG&A")(2) $113.8 $71.1 60.1 %$345.2 $236.7 45.8 %

Adjusted SG&A as a % of Total revenues15.0 %14.3 %70 bps15.3 %16.5 %(120 bps)

Net income (loss)$6.4 $(24.4)N/A*$61.8 $(36.2)N/A*

Adjusted EBITDA(2) $16.1 $2.1 666.7 %$97.2 $45.0 116.0 %

Adjusted Net income(2) $15.4 $1.7 805.9 %$95.5 $43.7 118.5 %

Total cash, cash equivalents, and investments$512.6 $395.9 29.5 %$512.6 $395.9 29.5 %

Insurance Segment:

Average Medicare Advantage membership(5) 158,383 108,231 46.3 %156,610 105,228 48.8 %

Insurance revenue$748.8 $479.1 56.3 %$2,230.7 $1,405.9 58.7 %

Insurance net medical claims incurred$654.1 $428.9 52.5 %$1,879.5 $1,191.0 57.8 %

Insurance BER(3) 91.1 %93.5 %(240 bps)88.4 %89.4 %(100 bps)

1,2,3,4,5

2026 Financial Guidance

Current 2026 GuidancePrevious 2026 Guidance

Total revenues$2.97 billion - $3.00 billion$2.92 billion - $3.00 billion

GAAP Net income$25 million - $35 million$20 million - $35 million

Consolidated Gross profit(1) $540 million - $555 million$525 million - $555 million

Adjusted EBITDA(4) $75 million - $85 million$70 million - $85 million

Average Medicare Advantage membership157,000 - 158,000156,000 - 158,000

Lives under Clover Management

September 30, 2026September 30, 2025

Insurance members158,907 109,226

*Not presented as a % change because the current or prior period amount is zero or the amount for the line item changed from a gain to a loss (or vice versa) and thus yields a result that is not meaningful.

1 Consolidated Gross profit (Non-GAAP) is a non-GAAP financial measure and is calculated by taking net income (loss) before salaries and benefits, general and administrative expenses, depreciation and amortization, premium deficiency reserve expense, restructuring costs, imp

2026
Q2

Q2 2026 Earnings

8-K BUY

Aug 5, 2026 · 100% conf.

AI Prediction BUY

1D

+0.25%

$4.20

Act: +9.59%

5D

+13.75%

$4.76

20D

+11.24%

$4.66

Price: $4.19 Prob +5D: 100% AUC: 1.000
0001801170-26-000196

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.e618d017.1786368612.cadddbd4

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

2026
Q1

Q1 2026 Earnings

8-K BUY

May 6, 2026 · 100% conf.

AI Prediction BUY

1D

-0.75%

$2.66

Act: +5.22%

5D

+10.01%

$2.95

Act: +32.46%

20D

+3.71%

$2.78

Act: +48.88%

Price: $2.68 Prob +5D: 100% AUC: 1.000
0001801170-26-000114

EX-99.1

2 a1q26exx991xearningsrelease.htm

EX-99.1

Document

Exhibit 99.1

Clover Health Reports First Quarter 2026 Results

Business Highlights:

•Delivered positive GAAP Net Income in the first quarter of 2026, with strong performance across key metrics: Total revenues, Adjusted EBITDA, and Consolidated Gross Profit

•Market-leading Medicare Advantage membership growth with underlying trends tracking in line with expectations

•Expect to meet or exceed full year 2026 outlook across all metrics, including achieving first full year GAAP Net Income profitability

Financial Results:

•First quarter 2026 GAAP Net Income of $27 million, an improvement of $29 million year-over-year

•First quarter 2026 Medicare Advantage membership of 155,773, up 51% year-over-year, and Total revenues of $749 million, up 62% year-over-year

•First quarter 2026 Consolidated Gross Profit of $160 million, up 47% year-over-year, and Adjusted EBITDA of $40 million, up 56% year-over-year

Full Year 2026 Guidance:

•Average Medicare Advantage membership of 154,000 - 158,000, representing 46% growth year-over-year at the midpoint

•Total revenues between $2.81 billion and $2.92 billion, representing 49% growth year-over-year at the midpoint

•Consolidated Gross Profit between $470 million and $510 million, representing 38% growth year-over-year at the midpoint

•Adjusted EBITDA profitability between $50 million and $70 million

•GAAP Net Income between $0 million and $20 million

WILMINGTON, Del. – May 6, 2026 – Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the first quarter 2026. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights.

“Our results demonstrate the differentiated model we have built to drive growth and profitability while expanding access to high-quality, affordable care through a wide-network PPO,” said Clover Health CEO Andrew Toy. “During the first quarter, we delivered strong performance across key metrics, driven by deeper clinical engagement, with Clover Assistant supporting earlier intervention and better outcomes for our members. As we continue to scale our technology to reach more members, we expect to achieve our first full year of GAAP Net Income profitability in 2026.”

“We achieved positive GAAP Net Income in the first quarter of 2026 while continuing to grow at a market-leading rate,” said Clover Health Interim CFO Clay Thornton. “Results are developing in line with our expectations, and we are encouraged by early medical cost trend indicators across both new and returning cohorts. We expect to meet or exceed our full year 2026 outlook across all metrics, including our expectation to deliver GAAP Net Income profitability.”

1

Key Company highlights are as follows:

Three Months Ended March 31,

Dollars in Millions20262025Change (%)

Consolidated:

Total revenues $749.2 $462.3 62.1 %

Consolidated Gross profit(1) $159.5 $108.9 46.5 %

Salaries and benefits plus General and administrative expenses ("SG&A")$131.7 $109.7 20.1 %

Adjusted Salaries and benefits plus General and administrative expenses ("Adjusted SG&A")(2) $119.3 $83.1 43.6 %

Adjusted SG&A as a % of Total revenues15.9 %18.0 %(210) bps

Net income (loss)

$27.3 $(1.3)N/A*

Adjusted EBITDA(2) $40.3 $25.8 56.2 %

Adjusted Net income(2) $39.7 $25.3 56.9 %

Total cash, cash equivalents, and investments$418.2 $390.8 7.0 %

Insurance Segment:

Average Medicare Advantage membership(5) 154,607 101,959 51.6 %

Insurance revenue$744.2 $456.9 62.9 %

Insurance net medical claims incurred$610.0 $367.9 65.8 %

Insurance BER(3) 86.5 %86.1 %40 bps

1,2,3,4,5

2026 Financial Guidance

2026 Guidance

Total revenues $2.81 billion - $2.92 billion

Consolidated Gross profit(1) $470 million - $510 million

Adjusted EBITDA(4) $50 million - $70 million

GAAP Net income$0 million - $20 million

Average Medicare Advantage membership154,000 - 158,000

Lives under Clover Management

March 31, 2026March 31, 2025

Insurance members155,773 103,418

Earnings Conference Call Details

*Not presented as a % change because the current or prior period amount is zero or the amount for the line item changed from a gain to a loss (or vice versa) and thus yields a result that is not meaningful.

1 Consolidated Gross profit (Non-GAAP) is a non-GAAP financial measure and is calculated by taking net income (loss) before salaries and benefits, general and administrative expenses, depreciation and amortization, premium deficiency reserve expense, restructuring costs, impairment of goodwill and other intangible assets, interest expense, change in fair value of warrants, and loss on investment. A reconciliation of Consolidated Gross profit (Non-GAAP) to Net income, the most directly comparable GAAP measure is provided in the table immediately following the consolidated financial statements below. A reconciliation of projected Consolidated Gr

About Clover Health Investments Corp. (CLOV) Earnings

This page provides Clover Health Investments Corp. (CLOV) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.

Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on CLOV's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.

Share on Social Networks: